Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × Neoadjuvant Therapy × Clear all

Sponsor

Conditions

Breast Neoplasms 14 Esophageal Neoplasms 5 Adenocarcinoma Of Esophagus 5 Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Sarcoma 3 Rectal Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Multiple Myeloma 2 Kidney Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Breast Carcinoma In Situ 2 Vomiting 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Teratoma 1 Stomach Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Prostate Adenocarcinoma 1 Ovarian Neoplasms 1

Interventions

pazopanib 5 Doxorubicin 3 Bevacizumab 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Paclitaxel 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 talimogene laherparepvec 1 romidepsin 1 regorafenib 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 Vascular Endothelial Growth Factor A 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡